Turn Therapeutics TTRX
NASDAQ TTRX
$12.96 -0.35 (-2.67%)
As of: Oct 2, 2026 · 10:35 AM EDT

Turn Therapeutics (TTRX) Net Equity Issued and Repurchased (2024 - 2025)

Updated

Turn Therapeutics (TTRX) recorded Net Equity Issued and Repurchased of $3.18 million in Q4 2025, up 508.5% from $522,206 a year earlier and up 434.4% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends

For FY2025, Turn Therapeutics reported Net Equity Issued and Repurchased of $6.92 million, up 500.4% from FY2024.

  • Across earlier years, Net Equity Issued and Repurchased came in at $1.15 million in FY2024.
  • Per Business Quant, the preceding three quarters came in at $594,617 (Q3 2025), $2.15 million (Q2 2025) and $998,092 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Turn Therapeutics 428.65 Mn 428.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.18 Mn
Sep 30, 2025 594,617.00
Jun 30, 2025 2.15 Mn
Mar 31, 2025 998,092.00
Dec 31, 2024 522,206.00
API Access

Turn Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TTRX&period=max&api_key=YOUR_API_KEY